Assessment of the risk of cardiovascular adverse events in patients with chronic lymphocytic leukemia treated with BrutonÓ?s tyrosine kinase inhibitors

Assessment of the risk of cardiovascular adverse events in patients with chronic lymphocytic leukemia treated with

Authors

Publication Details

Journal
Revista Colombiana de Cardiología (English Edition)
Published
2025-12-18
DOI
https://doi.org/10.24875/rccare.m25000185
Primary Topic
Chronic Lymphocytic Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Assessment of the risk of cardiovascular adverse events in patients with chronic lymphocytic leukemia treated with BrutonÓ?s tyrosine kinase inhibitors

Tito Carrera-Rodríguez, Paola Omaña, Gina González-Robledo
Revista Colombiana de Cardiología (English Edition)
Chronic Lymphocytic Leukemia Research
article

Assessment of the risk of cardiovascular adverse events in patients with chronic lymphocytic leukemia treated with BrutonÓ?s tyrosine kinase inhibitors

Tito Carrera-Rodríguez, Paola Omaña, Gina González-Robledo
article en

Abstract

Assessment of the risk of cardiovascular adverse events in patients with chronic lymphocytic leukemia treated with

Revista Colombiana de Cardiología (English Edition)Vol. 32(5)
Openalex Percentile: Top 38%
Chronic Lymphocytic Leukemia Research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.